Open Access
| Issue |
E3S Web Conf.
Volume 131, 2019
2nd International Conference on Biofilms (ChinaBiofilms 2019)
|
|
|---|---|---|
| Article Number | 01017 | |
| Number of page(s) | 4 | |
| DOI | https://doi.org/10.1051/e3sconf/201913101017 | |
| Published online | 19 November 2019 | |
- T. Ueda, H. Tsubamoto, K. Inoue, K. Sakata, H. Shibahara, T. Sonoda, Itraconazole Modulates Hedgehog, WNT/ βcatenin, as well as Akt Signalling, and Inhibits Proliferation of Cervical Cancer Cells. Anticancer Res 7, 3521-3526 (2017). [Google Scholar]
- P. Pantziarka, V. Sukhatme, G. Bouche, L. Meheus, VP. Sukhatme, Repurposing Drugs in Oncology (ReDO)-itraconazole as an anti-cancer agent. Ecancermedicalscience 9, 521(2015). [PubMed] [Google Scholar]
- S. Bahmani, N. Azarpira, E. Moazamian, Anti-colon cancer activity of Bifidobacterium metabolites on colon cancer cell line SW742. Turk J Gastroenterol 9, 835-842 (2019). [Google Scholar]
- X. Liang, M. Luo, XW. Wei, et al., A folate receptor-targeted lipoplex delivering interleukin-15 gene for colon cancer immunotherapy. Oncotarget 32, 52207-52217 (2016). [Google Scholar]
- K. Ogata, H. Takamori, N. Umezaki, et al., Gastrointestinal perforation during regorafenib administration in a case with hepatic metastases of colon cancer. J Chemother 5, 314-316 (2017). [Google Scholar]
- F. Agüero, C. Murta-Nascimento, M. Gallén, et al., Colorectal cancer survival: results from a hospital-based cancer registry. Rev Esp Enferm Dig 11, 572577(2012). [Google Scholar]
- Y. Tashiro, M. Murakami, K. Otsuka, et al., Intrathoracic Hernia after Total Gastrectomy. Case Rep Gastroenterol 1, 1-6 (2016). [Google Scholar]
- J. Kim, BT. Aftab, JY. Tang, et al., Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists. Cancer Cell 1, 23-34 (2013). [Google Scholar]
- CM. Rudin, JR. Brahmer, RA. Juergens, et al., Phase 2 Study of Pemetrexed and Itraconazole as Second-Line Therapy for Metastatic Non-Squamous Non-Small Cell Lung Cancer. J Thorac Oncol 5, 619(2013). [Google Scholar]
- DJ. Kim, J. Kim, K. Spaunhurst, et al., Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma. J Clin Oncol 8, 745(2014). [Google Scholar]
- P. Pantziarka, V. Sukhatme, G. Bouche, L. Meheus, VP. Sukhatme, Repurposing Drugs in Oncology (ReDO)-itraconazole as an anti-cancer agent. Ecancermedicalscience 1, 485(2014). [Google Scholar]
- RE. Kast, G. Karpel-Massler, ME. Halatsch, CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomid. Oncotarget 18, 8052-8082 (2014). [Google Scholar]
- X. Yio, M. Diamond, L. Werther, et al., Trefoil factor family-1 mutations enhance gastric cancer cell invasion through distinct signaling pathways. Gastroenterology 6, 1696-1706 (2006). [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.